These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35731960)

  • 1. How Do Accredited Organizations Evaluate the Quality and Effectiveness of Their Human Research Protection Programs?
    Fernandez Lynch H; Taylor HA
    AJOB Empir Bioeth; 2023; 14(1):23-37. PubMed ID: 35731960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do N-of-1 Trials Need IRB Review?
    Cen R; Hussain A; Pak KJ; Mitchell G; Nikles J; Gaudreau S; Bazzano LA; Breault JL
    J Empir Res Hum Res Ethics; 2016 Jul; 11(3):250-5. PubMed ID: 27534588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Of Parachutes and Participant Protection: Moving Beyond Quality to Advance Effective Research Ethics Oversight.
    Lynch HF; Nicholls S; Meyer MN; Taylor HA;
    J Empir Res Hum Res Ethics; 2019 Jul; 14(3):190-196. PubMed ID: 30541368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Quality of Research Ethics Review and Oversight: A Systematic Analysis of Quality Assessment Instruments.
    Lynch HF; Abdirisak M; Bogia M; Clapp J
    AJOB Empir Bioeth; 2020; 11(4):208-222. PubMed ID: 32821021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "We measure what we can measure": Struggles in defining and evaluating institutional review board quality.
    Lynch HF; Eriksen W; Clapp JT
    Soc Sci Med; 2022 Jan; 292():114614. PubMed ID: 34861569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development and acceptance of a simple tool to aid IRB compliance.
    Vulcano DM
    Qual Manag Health Care; 2012; 21(3):203-8. PubMed ID: 22722526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accreditation of human research protection program: An Indian perspective.
    Bairy KL; Pereira P
    Perspect Clin Res; 2012 Apr; 3(2):80-4. PubMed ID: 22701825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A snapshot of U.S. IRB review of COVID-19 research in the early pandemic.
    Taylor HA; Serpico K; Lynch HF; Baumann J; Anderson EE
    J Clin Transl Sci; 2021; 5(1):e205. PubMed ID: 34956653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cross Sectional Survey of Recruitment Practices, Supports, and Perceived Roles for Unaffiliated and Non-scientist Members of IRBs.
    Nicholls SG; Taylor HA; James R; Anderson EE; Friesen P; Schonfeld T; Summers EI
    AJOB Empir Bioeth; 2023; 14(3):174-184. PubMed ID: 36821084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of human research participants: accreditation of programmes in the Indian context.
    Bhosale N; Nigar S; Das S; Divate U; Divate P
    Indian J Med Ethics; 2014; 11(1):55-9. PubMed ID: 24509113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institutional review board challenges related to community-based participatory research on human exposure to environmental toxins: a case study.
    Brown P; Morello-Frosch R; Brody JG; Altman RG; Rudel RA; Senier L; Pérez C; Simpson R
    Environ Health; 2010 Jul; 9():39. PubMed ID: 20637068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The difference in acknowledging the AAHRPP between China and America].
    Zi MJ; Tang XD; Gao R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Aug; 32(8):1117-20. PubMed ID: 23173265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives of Singaporean biomedical researchers and research support staff on actual and ideal IRB review functions and characteristics: A quantitative analysis.
    Labude MK; Shen L; Zhu Y; Schaefer GO; Ong C; Xafis V
    PLoS One; 2020; 15(12):e0241783. PubMed ID: 33382683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making Metrics Meaningful: How Human Research Protection Programs Can Efficiently and Effectively Use Their Data.
    Serpico K
    Ethics Hum Res; 2021 Sep; 43(5):26-35. PubMed ID: 34496157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusive, engaged, and accountable institutional review boards.
    Anderson EE; Johnson A; Lynch HF
    Account Res; 2024 Nov; 31(8):1287-1295. PubMed ID: 37272596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing communication among data monitoring committees and institutional review boards.
    Taylor HA; Chaisson L; Sugarman J
    Clin Trials; 2008; 5(3):277-82. PubMed ID: 18559418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the quality of VA Human Research Protection Programs: VA vs. affiliated University Institutional Review Board.
    Tsan MF; Nguyen Y; Brooks R
    J Empir Res Hum Res Ethics; 2013 Apr; 8(2):153-60. PubMed ID: 23651939
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.